Growth hormone peptides and recovery-focused compounds represent one of the most actively researched areas in peptide science. CJC-1295 belongs to this category, with research exploring its potential effects on growth hormone signaling, tissue repair, and recovery processes.
A synthetic GHRH analog with extended half-life via albumin binding. Studied for sustained stimulation of growth hormone and IGF-1 secretion over days to weeks.
Also Known As
Modified GRF (1-29), Mod GRF 1-29
What is CJC-1295?
CJC-1295 is classified under the GH / Recovery category of peptides. A synthetic GHRH analog with extended half-life via albumin binding. Studied for sustained stimulation of growth hormone and IGF-1 secretion over days to weeks.
Mechanism of Action: A synthetic analog of growth hormone-releasing hormone (GHRH) with amino acid substitutions at positions 2, 8, 15, and 27 that confer resistance to enzymatic degradation, extending its half-life compared to native GHRH.
Growth Hormone & Recovery Research
Primary Research Areas: Growth hormone secretion, body composition, age-related GH decline, metabolic research.
Key Research Findings: Clinical studies have shown CJC-1295 can increase GH and IGF-1 levels in a dose-dependent manner with sustained effects. When combined with a GHRP, it produces synergistic GH release mimicking natural pulsatile secretion patterns.
Safety Profile & Considerations
May cause injection site reactions, headache, flushing, and diarrhea. Long-term safety data in humans is limited. Potential concerns about sustained IGF-1 elevation.
Related Research Topics
Understanding CJC-1295 requires familiarity with these related concepts in gh / recovery research. Each topic represents a broader field that intersects with current peptide research.
References & Further Reading
Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805.
Stay Updated on Peptide Research
Get the latest science-backed articles on peptides delivered to your inbox.